Interventions to address sexual problems in people with cancer: American society of clinical oncology clinical practice guideline adaptation of cancer care Ontario guideline

Journal of Clinical Oncology

Volumn 36, Issue 5, 2018, Pages 492-511

  Carter, Jeanne ^a   Lacchetti, Christina ^c   Andersen, Barbara L ^a   Barton, Debra L ^e   Bolte, Sage ^d   Damast, Shari ^f   Diefenbach, Michael A ^b   DuHamel, Katherine ^a   Florendo, Judith ^g   Ganz, Patricia A ⁱ   Goldfarb, Shari ^a   Hallmeyer, Sigrun ^h   Kushner, David M ^j   Rowland, Julia H ^j  

^a OHIO STATE UNIVERSITY   (United States)

^b Northwell Health   (United States)

^c AMERICAN SOCIETY OF CLINICAL ONCOLOGY   (United States)

^d Department of Inova ^*  (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Doctor of Physical Therapy   (United States)

^h Oncology Specialists   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF WISCONSIN MADISON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; CLONIDINE; ESTROGEN; FLIBANSERIN; GABAPENTIN; LIDOCAINE; LUBRICATING AGENT; OSPEMIFENE; PAROXETINE; PHOSPHODIESTERASE V INHIBITOR; PRASTERONE; TESTOSTERONE; VENLAFAXINE;

ARTICLE; BODY IMAGE; BREAST CANCER; BREATHING EXERCISE; CANCER PATIENT; COGNITIVE BEHAVIORAL THERAPY; DYSPAREUNIA; ERECTILE DYSFUNCTION; FECES INCONTINENCE; GYNECOLOGICAL EXAMINATION; HEALTH CARE PERSONNEL; HUMAN; HYPNOSIS; HYPOACTIVE SEXUAL DESIRE DISORDER; INTIMACY; LOWER URINARY TRACT SYMPTOM; PATIENT CARE; PATIENT COUNSELING; PATIENT EDUCATION; PHYSIOTHERAPY; POSTMENOPAUSE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOTHERAPY; SCIENTIFIC LITERATURE; SCREENING; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL EDUCATION; SEXUAL FUNCTION; SEXUAL SATISFACTION; SEXUALITY; STRESS INCONTINENCE; TREATMENT OUTCOME; URINE INCONTINENCE; VAGINA ATROPHY; VAGINA PAIN; VASOMOTOR DISORDER; VULVA DISEASE; COMPLICATION; FEMALE; MALE; NEOPLASM; PSYCHOLOGY; PSYCHOSEXUAL DISORDER;

FEMALE; HUMANS; MALE; NEOPLASMS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 85041905211     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2017.75.8995     Document Type: Article

References (152)

1. Jemal A, Ward EM, Johnson CJ, et al: Annual report to the nation on the status of cancer, 1975-2014, featuring survival. J Natl Cancer Inst 109:109, 2017
2. White ID: Sexual difficulties after pelvic radiotherapy: Improving clinical management. Clin Oncol (R Coll Radiol) 27:647-655, 2015
3. Zhou ES, Nekhlyudov L, Bober SL: The primary health care physician and the cancer patient: Tips and strategies for managing sexual health. Transl Androl Urol 4:218-231, 2015
4. Hendren SK, O'Connor BI, Liu M, et al: Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. Ann Surg 242:212-223, 2005
5. Andersen BL, DeRubeis RJ, Berman BS, et al: Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: An American Society of Clinical Oncology guideline adaptation. J Clin Oncol 32:1605-1619, 2014
6. Weaver KE, Forsythe LP, Reeve BB, et al: Mental and physical health-related quality of life among U.S. cancer survivors: Population estimates from the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 21:2108-2117, 2012
7. Flynn KE, Reese JB, Jeffery DD, et al: Patient experiences with communication about sex during and after treatment for cancer. Psychooncology 21: 594-601, 2012
8. White ID, Faithfull S, Allan H: The reconstruction of women's sexual lives after pelvic radiotherapy: A critique of social constructionist and biomedical perspectives on the study of female sexuality after cancer treatment. Soc Sci Med 76: 188-196, 2013
9. Bober SL, Reese JB, Barbera L, et al: How to ask and what to do: A guide for clinical inquiry and intervention regarding female sexual health after cancer. Curr Opin Support Palliat Care 10:44-54, 2016
10. Dizon DS, Suzin D, McIlvenna S: Sexual health as a survivorship issue for female cancer survivors. Oncologist 19:202-210, 2014
11. Stead ML, Brown JM, Fallowfield L, et al: Lack of communication between healthcare professionals and women with ovarian cancer about sexual issues. Br J Cancer 88:666-671, 2003
12. Hordern AJ, Street AF: Communicating about patient sexuality and intimacy after cancer: Mismatched expectations and unmet needs. Med J Aust 186:224-227, 2007
13. Forbat L, White I, Marshall-Lucette S, et al: Discussing the sexual consequences of treatment in radiotherapy and urology consultations with couples affected by prostate cancer. BJU Int 109:98-103, 2012
14. Jaspers L, Feys F, Bramer WM, et al: Efficacy and safety of flibanserin for the treatment of hypoactive sexual desire disorder in women: A systematic review and meta-analysis. JAMA Intern Med 176: 453-462, 2016
15. Gao Z, Yang D, Yu L, et al: Efficacy and safety of flibanserin in women with hypoactive sexual desire disorder: A systematic reviewand meta-analysis. J Sex Med 12:2095-2104, 2015
16. Barton DL, Schroeder KCF, Banerjee T, et al: Efficacy of a biobehavioral intervention for hot flashes: A randomized controlled pilot study. Menopause 24:774-782, 2017
17. Elkins G, Marcus J, Stearns V, et al: Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors. J Clin Oncol 26:5022-5026, 2008
18. Elkins GR, Fisher WI, Johnson AK, et al: Clinical hypnosis in the treatment of postmenopausal hot flashes: A randomized controlled trial. Menopause 20:291-298, 2013
19. The North American Menopause Society: Nonhormonal management of menopauseassociated vasomotor symptoms: 2015 position statement of The North American Menopause Society. Menopause 22:1155-1172. 2015
20. Labrie F, Archer DF, KoltunW, et al: Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. Menopause 23: 243-256, 2016
21. Labrie F, Archer D, Bouchard C, et al: Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration. Menopause 16: 897-906, 2009
22. Labrie F, Archer D, Bouchard C, et al: Intravaginal dehydroepiandrosterone (prasterone), a physiological and highly efficient treatment of vaginal atrophy. Menopause 16:907-922, 2009
23. Labrie F, Archer D, Bouchard C, et al: Effect of intravaginal dehydroepiandrosterone (prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause 16:923-931, 2009
24. Bruyniks N, Nappi RE, Castelo-Branco C, et al: Effect of ospemifene on moderate or severe symptoms of vulvar and vaginal atrophy. Climacteric 19:60-65, 2016
25. Constantine G, Graham S, Portman DJ, et al: Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: Results of a randomized, placebo-controlled trial. Climacteric 18:226-232, 2015
26. Cui Y, Zong H, Yan H, et al: The efficacy and safety of ospemifene in treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy: A systematic review and meta-analysis. J Sex Med 11:487-497, 2014
27. Morgan S, Davies S, Palmer S, et al: Sex, drugs, and rock 'n' roll: Caring for adolescents and young adults with cancer. J Clin Oncol 28:4825-4830, 2010
28. Levine J, Canada A, Stern CJ: Fertility preservation in adolescents and young adults with cancer. J Clin Oncol 28:4831-4841, 2010
29. Shojania KG, Sampson M, Ansari MT, et al: How quickly do systematic reviews go out of date A survival analysis. Ann Intern Med 147:224-233, 2007
30. Antonini G, BusettoGM, De Berardinis E, et al: Minimally invasive infrapubic inflatable penile prosthesis implant for erectile dysfunction: Evaluation of efficacy, satisfaction profile and complications. Int J Impot Res 28:4-8, 2016
31. Gentile G, Franceschelli A, Massenio P, et al: Patient's satisfaction after 2-piece inflatable penile prosthesis implantation: An Italian multicentric study. Arch Ital Urol Androl 88:1-3, 2016
32. Egydio PH, Kuehhas FE: Penile lengthening and widening without grafting according to a modified 'sliding' technique. BJU Int 116:965-972, 2015
33. Martinez-Salamanca JI, Espinó s EL, Moncada I, et al: Management of end-stage erectile dysfunction and stress urinary incontinence after radical prostatectomy by simultaneous dual implantation using a single trans-scrotal incision: Surgical technique and outcomes. Asian J Androl 17:792-796, 2015
34. Yiou R, Binhas M: Combined implantation of a penile prosthesis and adjustable continence therapy ProACT in patients with erectile dysfunction and urinary incontinence after radical prostatectomy: Results of a prospective pilot study. J Sex Med 12: 2481-2484, 2015
35. Dieckmann KP, Anheuser P, Schmidt S, et al: Testicular prostheses in patients with testicular cancer-acceptance rate and patient satisfaction. BMC Urol 15:16, 2015
36. Catanzariti F, Polito B, Polito M: Testicular prosthesis: Patient satisfaction and sexual dysfunctions in testis cancer survivors. Arch Ital Urol Androl 88:186-188, 2016
37. Flynn KE, Lindau ST, Lin L, et al: Development and validation of a single-item screener for selfreporting sexual problems in U.S. adults. J Gen Intern Med 30:1468-1475, 2015
38. Hatzichristou D, Rosen RC, Derogatis LR, et al: Recommendations for the clinical evaluation of men and women with sexual dysfunction. J Sex Med 7: 337-348, 2010
39. McGahuey CA, Gelenberg AJ, Laukes CA, et al: The Arizona Sexual Experience Scale (ASEX): Reliability and validity. J Sex Marital Ther 26:25-40, 2000
40. Rosen R, Brown C, Heiman J, et al: The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26: 191-208, 2000
41. Cappelleri JC, Rosen RC: The Sexual Health Inventory for Men (SHIM): A 5-year review of research and clinical experience. Int J Impot Res 17: 307-319, 2005
42. Abraham L, Symonds T, Morris MF: Psychometric validation of a sexual quality of life questionnaire for use in men with premature ejaculation or erectile dysfunction. J Sex Med 5:595-601, 2008
43. DuHamel K, Schuler T, Nelson C, et al: The sexual health of female rectal and anal cancer survivors: Results of a pilot randomized psychoeducational intervention trial. J Cancer Surviv 10: 553-563, 2016
44. Ganz PA, Greendale GA, Petersen L, et al: Managing menopausal symptoms in breast cancer survivors: Results of a randomized controlled trial. J Natl Cancer Inst 92:1054-1064, 2000
45. Chung E: Penile prosthesis implant: Scientific advances and technological innovations over the last four decades. Transl Androl Urol 6:37-45, 2017
46. Mulcahy JJ: The development of modern penile implants. Sex Med Rev 4:177-189, 2016
47. Montague DK, Jarow JP, Broderick GA, et al: Chapter 1: The management of erectile dysfunction: An AUA update. J Urol 174:230-239, 2005
48. Howlader N, Noone AM, Krapcho M, et al: SEER cancer statistics review, 1975-2013, 2016. http://seer.cancer.gov/csr/1975-2013
49. Mead H, Cartwright-Smith L, Jones K, et al: Racial and Ethnic Disparities in U.S. Health Care: A Chartbook. New York, NY, The Commonwealth Fund, 2008
50. American Cancer Society: Cancer facts and figures for African Americans 2016-2018, 2016. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-facts-and-figures-forafrican-A mericans/cancer-facts-and-figures-for-africanamericans-2016-2018.pdf
51. US Cancer Statistics Working Group: United States Cancer Statistics: 1999-2014 Cancer Incidence and Mortality Data, 2017. https://www. cdc.gov/uscs
52. Bradford A, Fellman B, Urbauer D, et al: Assessment of sexual activity and dysfunction in medically underserved women with gynecologic cancers. Gynecol Oncol 139:134-140, 2015
53. Griggs J, Maingi S, Blinder V, et al: American Society of Clinical Oncology position statement: Strategies for reducing cancer health disparities among sexual and gender minority populations. J Clin Oncol 35:2203-2208, 2017
54. Loren AW, Mangu PB, Beck LN, et al: Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31:2500-2510, 2013
55. Ferrell BR, Temel JS, Temin S, et al: Integration of palliative care into standard oncology care: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 35:96-112, 2017
56. Kalaitzi C, Papadopoulos VP, Michas K, et al: Combined brief psychosexual intervention after mastectomy: Effects on sexuality, body image, and psychological well-being. J Surg Oncol 96:235-240, 2007
57. Jun EY, Kim S, Chang SB, et al: The effect of a sexual life reframing program on marital intimacy, body image, and sexual function among breast cancer survivors. Cancer Nurs 34:142-149, 2011
58. Mathias C, Cardeal Mendes CM, Pondé de Sena E, et al: An open-label, fixed-dose study of bupropion effect on sexual function scores in women treated for breast cancer. Ann Oncol 17:1792-1796, 2006
59. Brotto LA, Erskine Y, Carey M, et al: A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus wait-list control in women treated for gynecologic cancer. Gynecol Oncol 125:320-325, 2012
60. Schroder M, Mell LK, Hurteau JA, et al: Clitoral therapy device for treatment of sexual dysfunction in irradiated cervical cancer patients. Int J Radiat Oncol Biol Phys 61:1078-1086, 2005
61. Hersch J, Juraskova I, Price M, et al: Psychosocial interventions and quality of life in gynaecological cancer patients: A systematic review. Psychooncology 18:795-810, 2009
62. Scott JL, Kayser K: A review of couple-based interventions for enhancing women's sexual adjustment and body image after cancer. Cancer J 15: 48-56, 2009
63. Baucom DH, Porter LS, Kirby JS, et al: A couple-based intervention for female breast cancer. Psychooncology 18:276-283, 2009
64. Sharif F, Abshorshori N, Tahmasebi S, et al: The effect of peer-led education on the life quality of mastectomy patients referred to breast cancerclinics in Shiraz, Iran 2009. Health Qual Life Outcomes 8:74, 2010
65. Duijts SF, van Beurden M, Oldenburg HS, et al: Efficacy of cognitive behavioral therapy and physical exercise in alleviating treatment-induced menopausal symptoms in patients with breast cancer: Results of a randomized, controlled, multicenter trial. J Clin Oncol 30:4124-4133, 2012
66. Yang EJ, Lim JY, Rah UW, et al: Effect of a pelvic floormuscle training program on gynecologic cancer survivors with pelvic floor dysfunction: A randomized controlled trial. Gynecol Oncol 125: 705-711, 2012
67. Decker CL, Pais S, Miller KD, et al: A brief intervention to minimize psychosexual morbidity in dyads coping with breast cancer. Oncol Nurs Forum 39:176-185, 2012
68. Classen CC, Chivers ML, Urowitz S, et al: Psychosexual distress in women with gynecologic cancer: A feasibility study of an online support group. Psychooncology 22:930-935, 2013
69. Taylor S, Harley C, Ziegler L, et al: Interventions for sexual problems following treatment for breast cancer: A systematic review. Breast Cancer Res Treat 130:711-724, 2011
70. Miles T, Johnson N: Vaginal dilator therapy for women receiving pelvic radiotherapy. Cochrane Database Syst Rev 9:CD007291, 2010
71. Johnson N, Miles TP, Cornes P: Dilating the vagina to prevent damage from radiotherapy: Systematic review of the literature. BJOG 117:522-531, 2010
72. Rowland JH, Meyerowitz BE, Crespi CM, et al: Addressing intimacy and partner communication after breast cancer: A randomized controlled group intervention. Breast Cancer Res Treat 118:99-111, 2009
73. Marcus AC, Garrett KM, Cella D, et al: Can telephone counseling post-treatment improve psychosocial outcomes among early stage breast cancer survivors Psychooncology 19:923-932, 2010
74. Schover LR, Yuan Y, Fellman BM, et al: Efficacy trial of an Internet-based intervention for cancerrelated female sexual dysfunction. J Natl Compr Canc Netw 11:1389-1397, 2013
75. Sismondi P, Kimmig R, Kubista E, et al: Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients-data from LIBERATE trial. Maturitas 70:365-372, 2011
76. Schover LR, Rhodes MM, Baum G, et al: Sisters Peer Counseling in Reproductive Issues After Treatment (SPIRIT): A peer counseling program to improve reproductive health among African American breast cancer survivors. Cancer 117:4983-4992, 2011
77. Ayaz S, Kubilay G: Effectiveness of the PLISSIT model for solving the sexual problems of patients with stoma. J Clin Nurs 18:89-98, 2009
78. Juraskova I, Jarvis S, Mok K, et al: The acceptability, feasibility, and efficacy (phase I/II study) of the OVERcome (Olive Oil, Vaginal Exercise, and MoisturizeR) intervention to improve dyspareunia and alleviate sexual problems in women with breast cancer. J Sex Med 10:2549-2558, 2013
79. Reid R, Abramson BL, Blake J, et al: Managing menopause. J Obstet Gynaecol Can 36:830-833, 2014
80. North American Menopause Society: The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause 19:257-271, 2012
81. The North American Menopause Society: Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause 20:888-902, 2013
82. Lee YK, Chung HH, Kim JW, et al: Vaginal pHbalanced gel for the control of atrophic vaginitis among breast cancer survivors: A randomized controlled trial. Obstet Gynecol 117:922-927, 2011
83. Law E, Kelvin JF, Thom B, et al: Prospective study of vaginal dilator use adherence and efficacy following radiotherapy. Radiother Oncol 116: 149-155, 2015
84. Witherby S, Johnson J, Demers L, et al: Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: A phase I/II study. Oncologist 16:424-431, 2011
85. Candy B, Jones L, Vickerstaff V, et al: Interventions for sexual dysfunction following treatments for cancer in women. Cochrane Database Syst Rev 2:CD005540, 2016
86. Montorsi F, McCullough A: Efficacy of sildenafil citrate in men with erectile dysfunction following radical prostatectomy: A systematic review of clinical data. J Sex Med 2:658-667, 2005
87. Park SY, Choi GS, Park JS, et al: Efficacy and safety of udenafil for the treatment of erectile dysfunction after total mesorectal excision of rectal cancer: A randomized, double-blind, placebocontrolled trial. Surgery 157:64-71, 2015
88. Ilic D, Hindson B, Duchesne G, et al: A randomised, double-blind, placebo-controlled trial of nightly sildenafil citrate to preserve erectile function after radiation treatment for prostate cancer. J Med Imaging Radiat Oncol 57:81-88, 2013
89. Watkins Bruner D, James JL, Bryan CJ, et al: Randomized, double-blinded, placebo-controlled crossover trial of treating erectile dysfunction with sildenafil after radiotherapy and short-term androgen deprivation therapy: Results of RTOG 0215. J Sex Med 8:1228-1238, 2011
90. Incrocci L, Hop WC, Slob AK: Efficacy of sildenafil in an open-label study as a continuation of a double-blind study in the treatment of erectile dysfunction after radiotherapy for prostate cancer. Urology 62:116-120, 2003
91. Incrocci L, Slagter C, Slob AK, et al: A randomized, double-blind, placebo-controlled, crossover study to assess the efficacy of tadalafil (Cialis) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma. Int J Radiat Oncol Biol Phys 66:439-444, 2006
92. Incrocci L, Slob AK, Hop WC: Tadalafil (Cialis) and erectile dysfunction after radiotherapy for prostate cancer: An open-label extension of a blinded trial. Urology 70:1190-1193, 2007
93. Harrington C, Campbell G, Wynne C, et al: Randomised, placebo-controlled, crossover trial of sildenafil citrate in the treatment of erectile dysfunction following external beam radiation treatment of prostate cancer. J Med Imaging Radiat Oncol 54: 224-228, 2010
94. Pace G, Del Rosso A, Vicentini C: Penile rehabilitation therapy following radical prostatectomy. Disabil Rehabil 32:1204-1208, 2010
95. Bannowsky A, Schulze H, van der Horst C, et al: Recovery of erectile function after nerve-sparing radical prostatectomy: Improvement with nightly low-dose sildenafil. BJU Int 101:1279-1283, 2008
96. Mosbah A, El Bahnasawy M, Osman Y, et al: Early versus late rehabilitation of erectile function after nerve-sparing radical cystoprostatectomy: A prospective randomized study. J Sex Med 8: 2106-2111, 2011
97. McCullough AR, Levine LA, Padma-Nathan H: Return of nocturnal erections and erectile function after bilateral nerve-sparing radical prostatectomy in men treated nightly with sildenafil citrate: Subanalysis of a longitudinal randomized double-blind placebo-controlled trial. J Sex Med 5:476-484, 2008
98. Montorsi F, Brock G, Stolzenburg JU, et al: Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: A randomised placebo-controlled study (REACTT). Eur Urol 65:587-596, 2014
99. Ricardi U, Gontero P, Ciammella P, et al: Efficacy and safety of tadalafil 20 mg on demand vs. tadalafil 5 mg once-a-day in the treatment of postradiotherapy erectile dysfunction in prostate cancer men: A randomized phase II trial. J Sex Med 7: 2851-2859, 2010
100. Pavlovich CP, Levinson AW, Su LM, et al: Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: Results of a randomized double-blind trial with placebo. BJU Int 112:844-851, 2013
101. Montorsi F, Brock G, Lee J, et al: Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nervesparing radical prostatectomy. Eur Urol 54:924-931, 2008
102. Canada AL, Neese LE, Sui D, et al: Pilot intervention to enhance sexual rehabilitation for couples after treatment for localized prostate carcinoma. Cancer 104:2689-2700, 2005
103. Schover LR, Canada AL, Yuan Y, et al: A randomized trial of internet-based versus traditional sexual counseling for couples after localized prostate cancer treatment. Cancer 118:500-509, 2012
104. Kö hler TS, Pedro R, Hendlin K, et al: A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy. BJU Int 100: 858-862, 2007
105. Zelefsky MJ, Shasha D, Branco RD, et al: Prophylactic sildenafil citrate improves select aspects of sexual function in men treated with radiotherapy for prostate cancer. J Urol 192:868-874, 2014
106. Engel JD: Effect on sexual function of a vacuum erection device post-prostatectomy. Can J Urol 18:5721-5725, 2011
107. Lin YH, Yu TJ, Lin VC, et al: Effects of early pelvic-floor muscle exercise for sexual dysfunction in radical prostatectomy recipients. Cancer Nurs 35: 106-114, 2012
108. Titta M, Tavolini IM, Dal Moro F, et al: Sexual counseling improved erectile rehabilitation after nonnerve-sparing radical retropubic prostatectomy or cystectomy-results of a randomized prospective study. J Sex Med 3:267-273, 2006
109. Cormie P, Newton RU, Taaffe DR, et al: Exercise maintains sexual activity in men undergoing androgen suppression for prostate cancer: A randomized controlled trial. Prostate Cancer Prostatic Dis 16:170-175, 2013
110. Hanisch LJ, Bryan CJ, James JL, et al: Impact of sildenafil on marital and sexual adjustment in patients and their wives after radiotherapy and shortterm androgen suppression for prostate cancer: Analysis of RTOG 0215. Support Care Cancer 20: 2845-2850, 2012
111. Nishizawa Y, Ito M, Saito N, et al: Male sexual dysfunction after rectal cancer surgery. Int J Colorectal Dis 26:1541-1548, 2011
112. Salonia A, Gallina A, Zanni G, et al: Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nervesparing radical prostatectomy. Eur Urol 53:564-570, 2008
113. Reese JB, Porter LS, Somers TJ, et al: Pilot feasibility study of a telephone-based couples intervention for physical intimacy and sexual concerns in colorectal cancer. J Sex Marital Ther 38:402-417, 2012
114. Dalkin BL, Christopher BA: Preservation of penile length after radical prostatectomy: Early intervention with a vacuum erection device. Int J Impot Res 19:501-504, 2007
115. Irani J, Salomon L, Oba R, et al: Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: A doubleblind, randomised trial. Lancet Oncol 11:147-154, 2010
116. Ramsawh HJ, Morgentaler A, Covino N, et al: Quality of life following simultaneous placement of penile prosthesis with radical prostatectomy. J Urol 174:1395-1398, 2005
117. Pahlajani G, Raina R, Jones JS, et al: Early intervention with phosphodiesterase-5 inhibitors after prostate brachytherapy improves subsequent erectile function. BJU Int 106:1524-1527, 2010
118. Pugh TJ, Mahmood U, Swanson DA, et al: Sexual potency preservation and quality of life after prostate brachytherapy and low-dose tadalafil. Brachytherapy 14:160-165, 2015
119. Fujioka H, Ishimura T, Sakai Y, et al: Erectile function after brachytherapy with external beam radiation for prostate cancer. Arch Androl 50:295-301, 2004
120. Ogura K, Ichioka K, Terada N, et al: Role of sildenafil citrate in treatment of erectile dysfunction after radical retropubic prostatectomy. Int J Urol 11: 159-163, 2004
121. Schiff JD, Bar-Chama N, Cesaretti J, et al: Early use of a phosphodiesterase inhibitor after brachytherapy restores and preserves erectile function. BJU Int 98:1255-1258, 2006
122. Mulhall JP, Parker M, Waters BW, et al: The timing of penile rehabilitation after bilateral nervesparing radical prostatectomy affects the recovery of erectile function. BJU Int 105:37-41, 2010
123. Megas G, Papadopoulos G, Stathouros G, et al: Comparison of efficacy and satisfaction profile, between penile prosthesis implantation and oral PDE5 inhibitor tadalafil therapy, in men with nervesparing radical prostatectomy erectile dysfunction. BJU Int 112:E169-E176, 2013
124. Menard J, Tremeaux JC, Faix A, et al: Erectile function and sexual satisfaction before and after penile prosthesis implantation in radical prostatectomy patients: A comparison with patients with vasculogenic erectile dysfunction. J Sex Med 8: 3479-3486, 2011
125. Mydlo JH, Viterbo R, Crispen P: Use of combined intracorporal injection and a phosphodiesterase-5 inhibitor therapy for men with a suboptimal response to sildenafil and/or vardenafil monotherapy after radical retropubic prostatectomy. BJU Int 95:843-846, 2005
126. Natali A, Masieri L, Lanciotti M, et al: A comparison of different oral therapies versus no treatment for erectile dysfunction in 196 radical nerve-sparing radical prostatectomy patients. Int J Impot Res 27:1-5, 2015
127. Ohebshalom M, Parker M, Guhring P, et al: The efficacy of sildenafil citrate following radiation therapy for prostate cancer: Temporal considerations. J Urol 174:258-262, 2005
128. Raina R, Agarwal A, Allamaneni SS, et al: Sildenafil citrate and vacuum constriction device combination enhances sexual satisfaction in erectile dysfunction after radical prostatectomy. Urology 65: 360-364, 2005
129. Raina R, Agarwal A, Goyal KK, et al: Long-term potency after iodine-125 radiotherapy for prostate cancer and role of sildenafil citrate. Urology 62: 1103-1108, 2003
130. Raina R, Pahlajani G, Agarwal A, et al: The early use of transurethral alprostadil after radical prostatectomy potentially facilitates an earlier return of erectile function and successful sexual activity. BJU Int 100:1317-1321, 2007
131. Balbontin FG, Moreno SA, Bley E, et al: Longacting testosterone injections for treatment of testosterone deficiency after brachytherapy for prostate cancer. BJU Int 114:125-130, 2014
132. Chisholm KE, McCabe MP, Wootten AC, et al: Review: Psychosocial interventions addressing sexual or relationship functioning in men with prostate cancer. J Sex Med 9:1246-1260, 2012
133. Porter LS, Keefe FJ, Baucom DH, et al: Partner-assisted emotional disclosure for patients with gastrointestinal cancer: Results from a randomized controlled trial. Cancer 115: 4326-4338, 2009 (suppl 18)
134. Porter LS, Keefe FJ, Baucom DH, et al: Partner-assisted emotional disclosure for patients with GI cancer: 8-week follow-up and processes associated with change. Support Care Cancer 20: 1755-1762, 2012
135. Chambers SK, Schover L, Halford K, et al: ProsCan for Couples: A feasibility study for evaluating peer support within a controlled research design. Psychooncology 22:475-479, 2013
136. Collins AL, Love AW, Bloch S, et al: Cognitive existential couple therapy for newly diagnosed prostate cancer patients and their partners: A descriptive pilot study. Psychooncology 22:465-469, 2013
137. Lassen B, Gattinger H, Saxer S: A systematic review of physical impairments following radical prostatectomy: Effect of psychoeducational interventions. J Adv Nurs 69:2602-2612, 2013
138. Molton IR, Siegel SD, Penedo FJ, et al: Promoting recovery of sexual functioning after radical prostatectomy with group-based stress management: The role of interpersonal sensitivity. J Psychosom Res 64:527-536, 2008
139. Siddons HM, Wootten AC, Costello AJ: A randomised, wait-list controlled trial: Evaluation of a cognitive-behavioural group intervention on psychosexual adjustment for men with localised prostate cancer. Psychooncology 22:2186-2192, 2013
140. Lee IH, Sadetsky N, Carroll PR, et al: The impact of treatment choice for localized prostate cancer on response to phosphodiesterase inhibitors. J Urol 179:1072-1076, 2008; discussion 1076
141. Vitolins MZ, Griffin L, Tomlinson WV, et al: Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer. J Clin Oncol 31: 4092-4098, 2013
142. Loprinzi CL, Dueck AC, Khoyratty BS, et al: A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB). Ann Oncol 20:542-549, 2009
143. Frisk J, Spetz AC, Hjertberg H, et al: Two modes of acupuncture as a treatment for hot flushes in men with prostate cancer-a prospective multicenter study with long-term follow-up. Eur Urol 55: 156-163, 2009
144. Moraska AR, Atherton PJ, Szydlo DW, et al: Gabapentin for the management of hot flashes in prostate cancer survivors: A longitudinal continuation Study-NCCTG Trial N00CB. J Support Oncol 8: 128-132, 2010
145. Ashamalla H, Jiang ML, Guirguis A, et al: Acupuncture for the alleviation of hot flashes in men treated with androgen ablation therapy. Int J Radiat Oncol Biol Phys 79:1358-1363, 2011
146. Beer TM, Benavides M, Emmons SL, et al: Acupuncture for hot flashes in patients with prostate cancer. Urology 76:1182-1188, 2010
147. Harding C, Harris A, Chadwick D: Auricular acupuncture: A novel treatment for vasomotor symptoms associated with luteinizing-hormone releasing hormone agonist treatment for prostate cancer. BJU Int 103:186-190, 2009
148. Loprinzi CL, Barton DL, Carpenter LA, et al: Pilot evaluation of paroxetine for treating hot flashes in men. Mayo Clin Proc 79:1247-1251, 2004
149. Naoe M, Ogawa Y, Shichijo T, et al: Pilot evaluation of selective serotonin reuptake inhibitor antidepressants in hot flash patients under androgen-deprivation therapy for prostate cancer. Prostate Cancer Prostatic Dis 9:275-278, 2006
150. Vandecasteele K, Ost P, Oosterlinck W, et al: Evaluation of the efficacy and safety of Salvia officinalis in controlling hot flashes in prostate cancer patients treated with androgen deprivation. Phytother Res 26:208-213, 2012
151. Carter J, Stabile C, Seidel B, et al: Vaginal and sexual health treatment strategies within a female sexual medicine program for cancer patients and survivors. J Cancer Surviv 11:274-283, 2017
152. Goetsch MF, Lim JY, Caughey AB: A practical solution for dyspareunia in breast cancer survivors: A randomized controlled trial. J Clin Oncol 33: 3394-3400, 2015